NCBI National Center for Biotechnology Information |
4F09: Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2 | |||||||||||||||
* Click molecule labels to explore molecular sequence information.
|